Инструкция по применению KLOFEND
Содержание инструкции
CLOFEND 7.08 mg/ml oral suspension
L-Cloperastine fendizoate
Read this leaflet carefully before taking this medicine as it contains
important information for you.
Always use this medicine exactly as described in this leaflet or as your doctor or
pharmacist has told you to do.
- Keep this leaflet. You may need to read it again.
- If you want more information or advice, ask your pharmacist.
- If any side effects occur, including effects not listed in this leaflet, tell your doctor or pharmacist. See section 4.
- See a doctor if you do not feel better or if your symptoms worsen after 7 days.
Contents of this leaflet:
- 1. What Clofend is and what it is used for
- 2. What you need to know before you take Clofend
- 3. How to take Clofend
- 4. Possible side effects
- 5. How to store Clofend
- 6. Contents of the pack and other information
1. What is Clofend and what is it used for
Clofend contains the active ingredient L-cloperastine fendizoate, which belongs to a group of
medicines called cough sedatives, which calm the cough by acting on the central
nervous system.
This medicine is indicated for the treatment of cough.
See your doctor if you do not feel better or if you feel worse after 7 days.
2. What you need to know before you take Clofend
Do not take Clofend
- if you are allergic to L-cloperastine fendizoate or any of the other ingredients of this medicine (listed in section 6);
- if the person who needs to take this medicine is a child between 0 and 2 years old (very early infancy).
Warnings and precautions
Talk to your doctor or pharmacist before taking Clofend.
Caution is advised when using.
- if you suffer from too much pressure inside the eye (elevated intraocular pressure or glaucoma);
- if you suffer from benign enlargement of the prostate (prostatic hypertrophy);
- if you have problems with urination (bladder obstruction);
- if you are taking other medicines, see “Other medicines and Clofend”.
Children
This medicine is contraindicated in children between 0 and 2 years of age (See section
“Do not take Clofend”).
Other medicines and Clofend
Tell your doctor or pharmacist if you are taking, have recently taken or might
take any other medicines.
Tell your doctor if you are taking the following medicines:
- medicines that act by depressing or stimulating the central nervous system;
- alcohol;
- antihistamines, used for the treatment of allergies, antiserotoninergics, used mainly for the treatment of depression and severe headaches (migraine), muscle relaxants such as papaverine (of the papaverinic type), used to reduce muscle contraction, because L-cloperastine can increase their effects.
Pregnancy and breastfeeding
If you are pregnant, suspect you may be pregnant or are planning to become pregnant, or if you
are breastfeeding with breast milk, ask your doctor or pharmacist for advice before taking this
medicine.
Avoid taking this medicine if you are in the first three months of pregnancy. In subsequent
months of pregnancy, take Clofend only when absolutely necessary and under the direct control of
your doctor.
Avoid taking Clofend during breastfeeding.
Driving and using machines
When taken at the recommended doses, this medicine does not alter the ability to drive
vehicles or use machinery.
Clofend contains methyl p-hydroxybenzoate and propyl p-hydroxybenzoate.These may cause
allergic reactions (even delayed).
Clofend contains sodium.This medicine contains less than 1 mmol (23 mg) of sodium per
5 ml dose, i.e. essentially ‘sodium-free’.
3. How to take Clofend
Use this medicine following exactly what is reported in this leaflet or the instructions of your doctor or pharmacist. If you have doubts, consult your doctor or pharmacist.
Read carefully the following instructions before taking Clofend:
- to open the bottle, press the cap downwards, unscrewing to the left;
- to close the bottle, screw the cap tightly to the right.
To dose the medicine, use the appropriate graduated measuring device (2-3-5 ml).
In adults, the recommended dose is 5 ml, 3 times a day.
Use in children
In children, the dose must be reduced, based on age:
- between 2 and 4 years: the recommended dose is 2 ml, 2 times a day.
- between 4 and 7 years: the recommended dose is 3 ml, 2 times a day.
- between 7 and 15 years: the recommended dose is 5 ml, 2 times a day.
Duration of treatment: 7 days. If no appreciable results are noticed, it is advisable to
consult your doctor.
Children under 2 years:the use of Clofend is contraindicated under two years,
see “What you need to know before taking Clofend”.
If you take more Clofend than you should
Following the assumption of an excessive dose of this medicine, symptoms of excessive excitation (overexcitation) may occur.
Drowsiness may occur.
The doctor will establish the most suitable therapy for you, based on your symptoms.
In case of accidental ingestion/assumption of an excessive dose of Clofend, immediately notify
your doctor or go to the nearest hospital.
If you forget to take Clofend
Do not take a double dose to compensate for forgetting the dose.
Take the normal next dose, at the scheduled time.
If you have any doubts about the use of this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects that may occur are:
- mild and temporary problems with the stomach and intestines (gastrointestinal disorders).
Uncommon side effects (may affect up to 1 in 100 people):
- dry mouth.
Side effects with unknown frequency (frequency cannot be estimated based on available data):
- hypersensitivity reactions including severe, rapidly appearing allergic reactions (anaphylactic/anaphylactoid reaction),
- urticaria,
- erythema.
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly through the national reporting system at
https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse . By reporting side effects you can help provide more information on the safety of this
medicine.
5. How to store Clofend
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after
“Exp.”.
The expiry date refers to the last day of that month and the product in intact packaging.
The product must be used within 6 weeks from the first opening of the bottle. Excess product must be discarded.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist
how to dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What Clofend contains
- The active ingredient is L-cloperastine fendizoate. 100 ml of suspension contains 708 mg of L-cloperastine fendizoate (equivalent to 400 mg of cloperastine hydrochloride).
- The other ingredients are: xanthan gum, macrogol stearate, xylitol, methyl p-hydroxybenzoate, propyl p-hydroxybenzoate, banana flavour, Sodium hydroxide, deionised water.
Description of the appearance of Clofend and contents of the pack
Yellow glass bottle with child-resistant cap containing a suspension with a fruity odour
and a sweet, pleasant taste. Oral suspension in 200 ml.
Marketing Authorisation Holder
FIDIA Farmaceutici S.p.A. – Via Ponte della Fabbrica 3/A – 35031 Abano Terme (PD) –
Italy
Manufacturer
Marco Viti Farmaceutici S.p.A. –Via Tarantelli, 13/15 - 22076 Mozzate (CO)
- Страна регистрации
- Форма выпускаOral suspension, 7.08 MG/ML
- Код АТХR05DB21
- Действующее вещество
- Отпускается по рецептуНет
- Производитель
- Информация на этой странице носит справочный характер и не является медицинской консультацией. Перед началом приема лекарства обязательно проконсультируйтесь с врачом.
- Аналоги KLOFENDФорма выпуска: Oral suspension, 708/100 MLДействующее вещество: cloperastineПроизводитель: AESCULAPIUS FARMACEUTICI SRLОтпускается без рецептаФорма выпуска: Coated tablet, 10 MGДействующее вещество: cloperastineПроизводитель: ZAMBON ITALIA S.R.L.Отпускается без рецептаФорма выпуска: Oral solution, 2.13 MG/MLДействующее вещество: pentoxyverineПроизводитель: OPELLA HEALTHCARE ITALY S.R.L.Отпускается без рецепта
Аналоги KLOFEND в других странах
Лекарства с тем же действующим веществом, доступные в других странах.
Аналог KLOFEND в Испания
Аналог KLOFEND в Украина
Врачи онлайн по KLOFEND
Обсудите применение KLOFEND и возможные следующие шаги — по оценке врача.
Получите рецепт на KLOFEND онлайн
Заполните форму за 2 минуты
Расскажите о симптомах, истории болезни и нужном препарате.
Выберите врача или мы назначим
Выберите специалиста или мы подберём ближайшего доступного врача.
Врач рассматривает ваш случай
Обычно в течение 30 минут. Может задать уточняющие вопросы в чате.
Получите в любой аптеке
Электронный рецепт отправляется на вашу почту — действителен по всей Польше.
Часто задаваемые вопросы
KLOFEND не требует рецепта в Италия. Вы можете уточнить у врача онлайн, подходит ли это лекарство для вашей ситуации.
Действующее вещество KLOFEND — cloperastine. Эта информация помогает определить лекарства с тем же составом под другими торговыми названиями.
KLOFEND производится компанией FIDIA FARMACEUTICI S.P.A.. Упаковка и торговое название могут отличаться в зависимости от дистрибьютора.
Врачи, включая Семейные врачи, Психиатры, Дерматологи, Кардиологи, Эндокринологи, Гастроэнтерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Инфекционисты, Аллергологи, Гериатры, Педиатры, Онкологи, могут оценить целесообразность применения KLOFEND с учетом вашей ситуации и местных правил. Вы можете записаться на онлайн-консультацию, чтобы обсудить возможные варианты.
Польша имеет хорошо развитую систему здравоохранения в крупных городах, таких как Варшава, Краков, Вроцлав и Гданьск. Аптеки широко доступны и работают в соответствии с действующим законодательством, обеспечивая доступ к рецептурным препаратам.
Вы можете купить KLOFEND в Варшаве, Кракове, Вроцлаве или Гданьске в любой аптеке при наличии действующего рецепта.
Чтобы получить рецепт, вы можете воспользоваться Oladoctor:
Другие лекарства с тем же действующим веществом (cloperastine) включают KLOEL, SEKI, BISOLSEK. Они могут отличаться торговым названием или формой выпуска, но содержат одинаковый терапевтический компонент. Перед изменением лечения рекомендуется проконсультироваться с врачом.
















